期刊文献+

尿培养中产超广谱β-内酰胺酶的大肠埃希菌检测与耐药性分析 被引量:2

下载PDF
导出
摘要 目的 了解尿培养中产超广谱β-内酰胺酶(ESBLs)的大肠埃希菌的发生率和耐药性,为临床合理选择抗生素提供依据。方法 用Microscan autoscan-4细菌药敏分析仪进行细菌鉴定、药敏分析和ESBLs测定。结果 在55株大肠埃希菌中ESBLs的检出率为54.55%,ESBLs产生菌株对复方新诺明、氨苄青霉素、环丙沙星、庆大霉素、头孢噻吩等常用抗生素的耐药性高达74.50%~85.50%,非ESBLs产生菌株达45.45%,对亚胺培南、丁胺卡那敏感。结论 治疗产ESBLs菌引起的尿路感染,应选用亚胺培南和含ESBLs抑制剂复合物以及根据药敏试验结果选用抗生素。
作者 张崇贞
出处 《右江民族医学院学报》 2006年第2期263-265,共3页 Journal of Youjiang Medical University for Nationalities
  • 相关文献

参考文献5

二级参考文献34

  • 1Hiramatsu K, Hanaki H, Ino T,et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility[J]. J Antimicrob Chemother, 1997, 40(1):135-136.
  • 2Keiichi Hiramatsu. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance[J]. The Lancet Infectious Diseases, 2001,1(3):147-155.
  • 3National Committee for Clinical Laboratory Standard, 2002. Performance Standards for Antimicrobial Susceptibility Testing. NCCLS, Wayne, Pa.
  • 4Rhomberg PR, Jones RN , MYSTIC Study Group. Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials:report from the MYSTIC Program (2002) in North America. Diagn Microbiol Infect Dis, 2003,47:365-372.
  • 5Pfaller MA, Jones RN , MYSTIC Study Group. Antimicrobial susceptibility of inducible Amp C β-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000. Int J Antimicrob Agents, 2002,19:383-388.
  • 6Sader HS, Biedenbach DJ ,Jones RN. Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis, 2003,47:361-364.
  • 7Sader HS, Gales AC, Pfaller MA, et al. Pathogen frequency and resistance patterns in Brazilian hospitals:summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis, 2001,5:200-214.
  • 8National committee for clinical laboratory standards.Performance standards for antibioial susceptibility testing,12th informational supplement,approved standard M100-S12[S].National Committee for Clinical Laboratory Standards,Wayne,Pa,2002.
  • 9Boniiglio q Laksai Y,Franchino L,et a1.Mechanisms of beta—lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey[J].J Antimicrob Chemther,1998,42:697—702.
  • 10Troillet N,Samore MH,Carmeli T,et a1.Imipenem—resistant Pseudomornas aeruginosa:risk factors and antibiotic susceptibility patterns[J].Clin Infect Dis.1997.25:1094.

共引文献329

同被引文献7

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部